Institutional shares held 13.2 Million
105K calls
38.7K puts
Total value of holdings $143M
$1.14M calls
$421K puts
Market Cap $93.5M
8,597,680 Shares Out.
Institutional ownership 153.14%
# of Institutions 121


Latest Institutional Activity in DCTH

Top Purchases

Q2 2025
Citadel Advisors LLC Shares Held: 803K ($8.74M)
Q2 2025
Marshall Wace, LLP Shares Held: 483K ($5.26M)
Q2 2025
Geode Capital Management, LLC Shares Held: 703K ($7.65M)
Q2 2025
State Street Corp Shares Held: 474K ($5.16M)
Q2 2025
Ikarian Capital, LLC Shares Held: 322K ($3.51M)

Top Sells

Q2 2025
Gilder Gagnon Howe & CO LLC Shares Held: 33.1K ($360K)
Q2 2025
Susquehanna International Group, LLP Shares Held: 74.7K ($812K)
Q2 2025
Soleus Capital Management, L.P. Shares Held: 25K ($272K)
Q2 2025
Vivo Capital, LLC Shares Held: 570K ($6.2M)
Q2 2025
Millennium Management LLC Shares Held: 250K ($2.72M)

About DCTH

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.


Insider Transactions at DCTH

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.01M Shares
From 8 Insiders
Conversion of derivative security 750K shares
Exercise of in-the-money or at-the-money derivatives securities 1.2M shares
Exercise of conversion of derivative security 58.7K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on DCTH

Follow DELCATH SYSTEMS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCTH shares.

Notify only if

Insider Trading

Get notified when an Delcath Systems, Inc. insider buys or sells DCTH shares.

Notify only if

News

Receive news related to DELCATH SYSTEMS, INC.

Track Activities on DCTH